KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Goodwill (2016 - 2025)

Historic Goodwill for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $1.8 billion.

  • Edwards Lifesciences' Goodwill rose 1016.63% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 1016.63%. This contributed to the annual value of $1.8 billion for FY2024, which is 5515.68% up from last year.
  • Latest data reveals that Edwards Lifesciences reported Goodwill of $1.8 billion as of Q3 2025, which was up 1016.63% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Goodwill registered a high of $1.8 billion during Q1 2025, and its lowest value of $1.1 billion during Q4 2022.
  • Moreover, its 5-year median value for Goodwill was $1.2 billion (2021), whereas its average is $1.3 billion.
  • The largest annual percentage gain for Edwards Lifesciences' Goodwill in the last 5 years was 5515.68% (2024), contrasted with its biggest fall of 1142.75% (2024).
  • Over the past 5 years, Edwards Lifesciences' Goodwill (Quarter) stood at $1.2 billion in 2021, then fell by 8.83% to $1.1 billion in 2022, then rose by 7.54% to $1.1 billion in 2023, then skyrocketed by 55.16% to $1.8 billion in 2024, then fell by 0.46% to $1.8 billion in 2025.
  • Its Goodwill was $1.8 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.8 billion in Q1 2025.